Theravance Biopharma, Inc. Annual Return On Equity in % from 2014 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Theravance Biopharma, Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2024.
  • Theravance Biopharma, Inc. Return On Equity for the quarter ending December 31, 2024 was -29.7 %, a 49.3% decline year-over-year.
  • Theravance Biopharma, Inc. annual Return On Equity for 2024 was -29.7 %, a 49.3% decline from 2023.
  • Theravance Biopharma, Inc. annual Return On Equity for 2023 was -19.9 %, a 101% decline from 2022.
  • Theravance Biopharma, Inc. annual Return On Equity for 2022 was 1.58K %, a 2542% increase from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -29.7 -9.81 -49.3% Jan 1, 2024 Dec 31, 2024
2023 -19.9 -1.6K -101% Jan 1, 2023 Dec 31, 2023
2022 1.58K +1.52K +2542% Jan 1, 2022 Dec 31, 2022
2021 59.7 -60.4 -50.3% Jan 1, 2021 Dec 31, 2021
2020 120 -23.8 -16.5% Jan 1, 2020 Dec 31, 2020
2019 144 +2.78K Jan 1, 2019 Dec 31, 2019
2018 -2.63K -2.49K -1823% Jan 1, 2018 Dec 31, 2018
2017 -137 -73.7 -117% Jan 1, 2017 Dec 31, 2017
2016 -63.1 +8.87 +12.3% Jan 1, 2016 Dec 31, 2016
2015 -72 +23.2 +24.3% Jan 1, 2015 Dec 31, 2015
2014 -95.2 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.